Dali Pharmaceuticalco.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 15.32 million compared to CNY 36.89 million a year ago. Net loss was CNY 5.38 million compared to CNY 2.55 million a year ago.

Basic loss per share from continuing operations was CNY 0.0245 compared to CNY 0.0116 a year ago. Diluted loss per share from continuing operations was CNY 0.0245 compared to CNY 0.0116 a year ago.